CONTEXT: A very brief update, but a potentially very important one. The FDA is convening the paediatric subcommittee to discuss how to effectively use PROs in oncology studies. We will keep you posted on any notable outcomes.
IMPACT: Medium
READ TIME: 1 min
Quality Level Mean [1 – 10]: 7
Source URL: https://www.bioworld.com/articles/506911-odac-pediatric-subcommittee-to-wade-in-on-pros-rwe?v=preview